Novel Echocardiographic Measurements of Right Ventricular–Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension
Journal of Personalized Medicine · 21.11.2023 · 13 (12) · 1627
DOI: 10.3390/jpm13121627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 21.11.2023. Verfasst von Weronika Topyła-Putowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Medical University of Lublin, 20-059 Lublin, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Currently, there are many parameters with proven prognostic significance in pulmonary hypertension (PH). Recently, the parameters defining right ventricular–pulmonary artery coupling (RVPAC) have gained clinical importance. In our study, we investigated the prognostic potential of previously known single echocardiographic parameters and new parameters reflecting RVPAC in patients with precapillary PH.
Objective
Our study aimed to evaluate the prognostic value of selected echocardiographic parameters and the neutrophil–lymphocyte ratio (NLR) in adults with precapillary PH.
Methods
This study included 39 patients (74% women; average age, 63 years) with precapillary PH: pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH). The mean follow-up period was 16.6 ± 13.3 months. Twelve patients (31%) died during the observation time. We measured several echocardiographic parameters, which reflect right ventricular function, pulmonary hemodynamics, and RVPAC. To assess disease progression and the patient’s functional capacity, the World Health Organization functional class (WHO FC) was determined. The patient’s physical capacity was also evaluated using the 6 min walk test (6MWT). The analysis included values of the N-terminal prohormone brain natriuretic peptide (NT-proBNP) and NLR.
Results
TAPSE × AcT and TAPSE/sPAP were shown to statistically and significantly correlate with PH predictors, including WHO-FC, 6MWT, and NT-proBNP. Univariate Cox proportional hazards regression analysis revealed that AcT, TAPSE, mPAP, TAPSE/sPAP, RAP, TRPG/AcT, TAPSE × AcT, and NLRs are good predictors of mortality in patients with PH. In addition, the ROC curve analysis showed that TAPSE × AcT is a better predictor of PH-related deaths than TAPSE/sPAP and TAPSE alone. In our study, patients with TAPSE × AcT values < 126.36 had shorter survival times (sensitivity = 72.7%; specificity = 80.0%).
Conclusions
TAPSE × AcT is a novel, promising, and practicable echocardiographic parameter reflecting RVPAC, which is comparable to TAPSE/sPAP. Moreover, TAPSE × AcT can be a useful parameter in assessing the severity and prognosis of patients with precapillary PH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Medical University of Lublin, 20-059 Lublin, Poland.
ORCID-Profile: Michał Tomaszewski
Zitieren
APA
Topyła-Putowska, W., Tomaszewski, M., Wojtkowska, A., & Wysokiński, A. (2023). Novel Echocardiographic Measurements of Right Ventricular–Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension. Journal of Personalized Medicine, 13(12), 1627. https://doi.org/10.3390/jpm13121627
Vancouver
Topyła-Putowska W, Tomaszewski M, Wojtkowska A, Wysokiński A. Novel Echocardiographic Measurements of Right Ventricular–Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension. Journal of Personalized Medicine. 2023;13(12):1627. doi:10.3390/jpm13121627
BibTeX
@article{TopyaPutowska2023,
author = {Topyła-Putowska, Weronika and Tomaszewski, Michał and Wojtkowska, Agnieszka and Wysokiński, Andrzej},
title = {Novel Echocardiographic Measurements of Right Ventricular–Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {12},
pages = {1627},
doi = {10.3390/jpm13121627}
}
EUVIMED